PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25022P0732Simplexa covid-19 testing supplies — Diasorin Molecular LLC

Diasorin Molecular LLC holds $16.5M across 436 federal awards. This PIID sits alongside 2 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

250-Network Contract Office 10 (36C250)
Awarding office
Diasorin Molecular LLC
Recipient
Oct 31, 2026
PoP end
$552K
Obligated
$645K
Potential
334516
NAICS
6630
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Diasorin Molecular LLC — $90

Contract facts

NONE
Contract number36C25022P0732
Also listed as36C250-22-P-0732
Agency250-Network Contract Office 10 (36C250)
Awarding office250-Network Contract Office 10 (36C250)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentDiasorin Molecular LLC
CAGE7V7H8
UEIKFFNMC55GHS5
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6630
Place of performanceCYPRESS CA
Pricing typeFirm Fixed Price
Extent competedNot Competed
Related solicitation36C25021Q1179
PoP startNov 1, 2021
PoP end (current)Oct 31, 2026
Obligated$552K
Current value$552K
Potential value$645K

SIMPLEXA COVID-19 TESTING SUPPLIES is a federal NONE award for 250-Network Contract Office 10 (36C250) held by Diasorin Molecular LLC. Estimated value $645K ($552K obligated). Current period of performance ends Oct 31, 2026. Last award drew 1 bidder. Place of performance: CYPRESS CA. Related solicitation 36C25021Q1179.

Recompete timing

Public
Expiring in 71 days

Current PoP ends Oct 31, 2026 (71 days remaining). Agencies typically plan 12–18 months ahead — at 2.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Diasorin Molecular LLC$16.5M obligated across 436 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$249K · 100% of firm total
Open full company profile

Related awards

Same incumbent
36C24126N0536
HERPES VIROLOGY AND HISTOLOGY TESTING REAGENTS AND SUPPLIES
$150K
Apr 30, 2027
W81K0022P0269
PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF TH…
$140K
Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25022P0732?

36C25022P0732 (Simplexa covid-19 testing supplies) is a 250-Network Contract Office 10 (36C250) award with a potential value of $645K, currently held by Diasorin Molecular LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-22-P-0732?

36C250-22-P-0732 is the dashed form of PIID 36C25022P0732 (Simplexa covid-19 testing supplies), held by Diasorin Molecular LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25022P0732?

250-Network Contract Office 10 (36C250) awarded 36C25022P0732 to Diasorin Molecular LLC (potential $645K).

Who is the incumbent on 36C25022P0732?

Diasorin Molecular LLC is the incumbent with $16.5M across 436 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2026.

When does Diasorin Molecular LLC’s 36C25022P0732 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25022P0732